SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 75.79 |
Enterprise Value ($M) | 5.14 |
Book Value ($M) | 60.14 |
Book Value / Share | 2.35 |
Price / Book | 1.26 |
NCAV ($M) | 58.91 |
NCAV / Share | 2.30 |
Price / NCAV | 1.29 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.35 |
Return on Assets (ROA) | -0.76 |
Return on Equity (ROE) | -0.85 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.64 |
Current Ratio | 5.64 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 71.60 |
Assets | 72.83 |
Liabilities | 12.68 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -85.94 |
Net Income | -81.41 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -43.75 |
Cash from Investing | 48.97 |
Cash from Financing | -0.03 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Gilead Sciences Inc | 13.90 | ||
13G/A | Perceptive Advisors Llc | 4.00 | -84.12 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
41,689 | 196,824 | 21.18 | |
22,757 | 99,173 | 22.95 | |
31,656 | 146,417 | 21.62 | |
24,520 | 151,233 | 16.21 | |
115,625 | 521,740 | 22.16 | |
(click for more detail) |
Similar Companies | |
---|---|
LIPO – Lipella Pharmaceuticals Inc. | LIXT – Lixte Biotechnology Holdings, Inc. |
LPCN – Lipocine Inc. | LQDA – Liquidia Corporation |
LSDI – Lucy Scientific Discovery Inc. |
Financial data and stock pages provided by
Fintel.io